Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial.
Ashram S, Bahig H, Barry A, Blanchette D, Celinksi A, Chung P, Darko J, Donath D, Doucet R, Erickson A, Giuliani M, Gopaul D, Hipwell S, Javor J, Kuk J, Lindsay P, Millman B, Oliver M, Pearce A, Russell C, Senthi S, Vu T, Warner A, Gaede S, Palma DA.
Ashram S, et al.
Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):1011-1015. doi: 10.1016/j.ijrobp.2022.05.035. Epub 2022 Jun 3.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35667527
Clinical Trial.
No abstract available.